{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:55:30Z","timestamp":1790913330090,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ajpath.2012.08.043","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T04:02:28Z","timestamp":1352865748000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Protective and Pathological Properties of IL-22 in Liver Disease"],"prefix":"10.1016","volume":"182","author":[{"given":"Melissa A.","family":"Cobleigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Robek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.08.043_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2012.08.043_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.gene.6364144","article-title":"Is there an interaction between interleukin-10 and interleukin-22?","volume":"6","author":"Wolk","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.ajpath.2012.08.043_bib3","doi-asserted-by":"crossref","first-page":"31335","DOI":"10.1074\/jbc.M005304200","article-title":"Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R","volume":"275","author":"Xie","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.08.043_bib4","doi-asserted-by":"crossref","first-page":"33676","DOI":"10.1074\/jbc.M204204200","article-title":"Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line: pathways that are shared with and distinct from IL-10","volume":"277","author":"Lejeune","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.08.043_bib5","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","article-title":"Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9","volume":"164","author":"Dumoutier","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib7","first-page":"43","article-title":"Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3","volume":"1","author":"Pan","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","article-title":"Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts","volume":"129","author":"Andoh","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib11","doi-asserted-by":"crossref","first-page":"20869","DOI":"10.1074\/jbc.M109.002923","article-title":"Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family","volume":"284","author":"Gad","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.08.043_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib13","doi-asserted-by":"crossref","first-page":"G960","DOI":"10.1152\/ajpgi.00126.2005","article-title":"IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression","volume":"289","author":"Brand","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2010.02.022","article-title":"Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities","volume":"401","author":"Pagliaccetti","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib15","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.08.043_bib16","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/gut.2007.130112","article-title":"The role of the novel Th17 cytokine IL-26 in intestinal inflammation","volume":"58","author":"Dambacher","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2012.08.043_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","article-title":"Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2012.08.043_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.08.043_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20091509","article-title":"Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells","volume":"207","author":"Crellin","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.08.043_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib28","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.08.043_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","article-title":"Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease","volume":"29","author":"Zenewicz","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2012.08.043_bib30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1084\/jem.20092054","article-title":"Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A","volume":"207","author":"Sonnenberg","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/mi.2010.22","article-title":"IL-22 defines a novel immune pathway of antifungal resistance","volume":"3","author":"De Luca","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2012.38","article-title":"Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection","author":"Klatt","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2012.08.043_bib36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","article-title":"In vivo consequences of liver-specific interleukin-22 expression: implications for human liver disease progression","volume":"54","author":"Park","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.gastro.2012.03.044","article-title":"Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection","volume":"143","author":"Feng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib39","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/icb.2011.79","article-title":"IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver","volume":"90","author":"Xiang","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib42","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0903416","article-title":"Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections","volume":"184","author":"Wilson","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib43","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.08.043_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.043_bib46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.24220","article-title":"Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL\/6 mice","volume":"60","author":"Geboes","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.043_bib47","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1053\/j.gastro.2011.06.051","article-title":"A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus","volume":"141","author":"Zhang","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib48","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.24486","article-title":"Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3","volume":"54","author":"Jiang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib49","doi-asserted-by":"crossref","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","article-title":"IL-22 is increased in active Crohn\u2019s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration","volume":"290","author":"Brand","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2012.08.043_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ibd.20315","article-title":"Linking genetic susceptibility to Crohn\u2019s disease with Th17 cell function: IL-22 serum levels are increased in Crohn\u2019s disease and correlate with disease activity and IL23R genotype status","volume":"14","author":"Schmechel","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajpath.2012.08.043_bib52","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.4049\/jimmunol.0904091","article-title":"IL-22 induces an acute-phase response","volume":"185","author":"Liang","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib53","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1084\/jem.20090900","article-title":"Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17","volume":"206","author":"Mu\u00f1oz","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib54","doi-asserted-by":"crossref","first-page":"G1019","DOI":"10.1152\/ajpgi.00239.2006","article-title":"IL-22-mediated liver cell regeneration is abrogated by SOCS-1\/3 overexpression in vitro","volume":"292","author":"Brand","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2008.04.113","article-title":"Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis","volume":"371","author":"Pusl","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2012.08.043_bib56","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.194.12.1755","article-title":"Blocking chemokine responsive to gamma-2\/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"194","author":"Kakimi","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.08.043_bib57","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI200421087","article-title":"MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs","volume":"113","author":"Sitia","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.08.043_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cyto.2007.11.016","article-title":"The role of interleukin-22 in hepatitis C virus infection","volume":"41","author":"Dambacher","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.ajpath.2012.08.043_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10620-011-1997-z","article-title":"Interleukin (IL)-17\/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection","volume":"57","author":"Foster","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2012.08.043_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.23273","article-title":"Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B","volume":"51","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2012.08.043_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1440-1746.2011.06782.x","article-title":"Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C","volume":"27","author":"Chang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2012.08.043_bib62","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1478-3231.2007.01518.x","article-title":"Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection","volume":"27","author":"Hennig","year":"2007","journal-title":"Liver Int"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012007195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012007195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:38:45Z","timestamp":1757601525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944012007195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0002944012007195"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.043","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective and Pathological Properties of IL-22 in Liver Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}